Skip to main content

Paulson Richard A.

In the past year, 2 open-market sale filings worth $137.2K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$137.2K
2 filings
Net
−$137.2K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Paulson Richard A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

KPTI Karyopharm Therapeutics Inc.

President and CEO42 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
May 15, 2026 (view filing)May 141 dayPaulson Richard A.President and CEOSSale−2.20K$9.50−$20.9K−0.8%269.7K after
Mar 3, 2026 (view filing)Mar 21 dayPaulson Richard A.President and CEOSSale−12.4K$9.41−$116.3K−4.4%267.0K after
Sep 16, 2025 (view filing)Sep 151 dayPaulson Richard A.President and CEOSSale−1.26K$6.43−$8.08K−1.5%84.0K after
May 7, 2025 (view filing)May 61 dayPaulson Richard A.President and CEOSSale−236$7.12−$1.68K−0.3%82.5K after
Apr 7, 2025 (view filing)Apr 43 daysPaulson Richard A.President and CEOSSale−245$3.74−$916.3−0.3%82.7K after
Mar 6, 2025 (view filing)Mar 42 daysPaulson Richard A.President and CEOSSale−11.7K$6.29−$73.6K−12.4%83.0K after
Feb 5, 2025 (view filing)Feb 41 dayPaulson Richard A.President and CEOSSale−4.10K$0.65−$2.66K−0.4%1.12M after
Jan 7, 2025 (view filing)Jan 61 dayPaulson Richard A.President and CEOSSale−4.05K$0.78−$3.16K−0.4%1.12M after
Dec 5, 2024 (view filing)Dec 41 dayPaulson Richard A.President and CEOSSale−3.62K$0.81−$2.93K−0.3%1.13M after
Nov 6, 2024 (view filing)Nov 51 dayPaulson Richard A.President and CEOSSale−3.67K$0.91−$3.34K−0.3%1.13M after

See all 42 trades at KPTI